Elvis Wianda is listed as a founder of BenchSci in a public accelerator portfolio dataset. Verify role and biography from primary sources before indexing.
Executive Intelligence
Elvis Wianda
Founder
Elvis Wianda is listed as a founder of BenchSci in a public accelerator portfolio dataset. Verify role and biography from primary sources before indexing.
In this profile
Quick Facts
- Role Founder
- Company BenchSci
- Country United States
- Industry AI in Healthcare
- Founded 2015
- Known For BenchSci's March 2026 EMET launch crystallizes a decade-long thesis — drug discovery's bottleneck is scientific infrastructure,…
- Status Active
- Last Reviewed Aug 2026
Executive Summary
Elvis Wianda is listed as a founder of BenchSci in a public accelerator portfolio dataset. Verify role and biography from primary sources before indexing.
Career Timeline
Verified company milestones linked to this executive’s organization.
-
2015
Company founded
BenchSci was founded in 2015 per the company profile source on file.
Source -
2015
Leadership
2015: BenchSci founded in Toronto; Liran Belenzon joined as co-founder and CEO after cold-messaging founders at Creative Destruction Lab.
Source -
2025
Development
December 9, 2025: BenchSci renewed two-year Merck ASCEND agreement for preclinical disease biology research.
Source -
2026
Product
2026: BenchSci launched EMET Agentic Research Environment after ten years of platform development.
Source
Connected Company
Connected Products
BenchSci — Biotechnology
EMET (Evidence Mapping and Exploratory Tool) agentic research environment and ASCEND AI platform decoding biomedical evidence…
View ProductIndustry Intelligence
Request a correction if you represent this company or believe information is inaccurate.